Deal & Capital Advisory

Raising capital for a frontier company means selling a thesis that most investors have not underwritten before. Long development cycles, revenue that depends on a regulatory decision, comparables that do not really compare. The process is different from a conventional raise and takes longer.

This unit runs it. Funding strategy and instrument choice, investor targeting based on who has actually written cheques into your sector, the materials and the data room, process management through diligence, and the negotiation up to signature. Afterwards, investor relations: reporting that arrives on time and tells the truth, which is what makes the next round easier.

We work with our Corporate Finance & Valuation unit on the model and the valuation, and with our Corporate, M&A & Governance lawyers on documentation and closing. One team holds the mandate rather than three advisers coordinating by email. Lequent invests no capital of its own, so there is no conflict to price in.

Typical mandates: a funding round, a strategic investor or corporate venture process, a secondary or partial exit, or investor relations after a raise that went quiet.